Phototoxic or Photoprotective?-Advances and Limitations of Titanium (IV) Oxide in Dermal Formulations-A Review

Int J Mol Sci. 2023 May 2;24(9):8159. doi: 10.3390/ijms24098159.

Abstract

The widespread role of titanium (IV) oxide (TiO2) in many industries makes this substance of broad scientific interest. TiO2 can act as both a photoprotector and photocatalyst, and the potential for its role in both applications increases when present in nanometer-sized crystals. Its sunlight-scattering properties are used extensively in sunscreens. Furthermore, attempts have been made to incorporate TiO2 into dermal formulations of photolabile drugs. However, the propensity to generate reactive oxygen species (ROS) rendering this material potentially cytotoxic limits its role. Therefore, modifications of TiO2 nanoparticles (e.g., its polymorphic form, size, shape, and surface modifications) are used in an effort to reduce its photocatalytic effects. This review provides an overview of the potential risks arising from and opportunities presented by the use of TiO2 in skin care formulations.

Keywords: dermal formulations; photoprotection; phototoxicity; titanium (IV) oxide.

Publication types

  • Review

MeSH terms

  • Dermatitis, Phototoxic*
  • Humans
  • Nanoparticles* / chemistry
  • Oxides
  • Titanium / chemistry

Substances

  • titanium dioxide
  • Titanium
  • Oxides

Grants and funding

This research received no external funding.